articleTop 1% cited

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

Radiotherapy and Oncology · 1992 · Vol. 25(4) · pp. 231–241

Jean-Claude Horiot✉(Centre Georges François Leclerc)R. Le Fur(Centre Henri Becquerel)T. Nguyen(Institut Jean Godinot)C Chenal(Centre Eugène Marquis)S Schraub(Hôpital Privé Jean Mermo)Simona Alfonsi(Hôpital de la Timone)G GardaniW. Van den BogaertS. Danczak(The Maria Sklodowska-Curie National Research Institute of Oncology)M. BollaM. van Glabbeke(European Organisation for Research and Treatment of Cancer)M. De Pauw(European Organisation for Research and Treatment of Cancer)

View via DOI Publisher page

Head and Neck Cancer Studies Lymphoma Diagnosis and Treatment Lung Cancer Treatments and MutationsMedicineHyperfractionationRegimenRadiation therapyCarcinomaNuclear medicineUrologySurvival analysisRandomized controlled trialInternal medicine

MeSH terms

CarcinomaCobalt RadioisotopesEuropeFollow-Up StudiesHumansLymph NodesLymphatic MetastasisNeoplasm StagingOropharyngeal NeoplasmsPharynxPrognosisRadiationRadiation InjuriesRadiation ToleranceRadiotherapy Dosage

Citations

682

FWCI

31.28

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003